Search Legislation

The Medicines (Advisory Bodies) (No. 2) Regulations 2005

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

  1. Introductory Text

  2. 1.Citation, commencement and interpretation

  3. 2.Amendments to the Act

  4. 3.Amendments to the Marketing Authorization Regulations

  5. 4.Amendments to the Clinical Trials Regulations

  6. 5.Amendments to other enactments

  7. 6.Transitional Provisions

  8. Signature

    1. SCHEDULE 1

      AMENDMENTS TO THE ACT

      1. 1.Amendment of section 3 of the Act

      2. 2.Amendment of section 4 of the Act

      3. 3.Amendment of section 132 of the Act

      4. 4.Amendment of Schedule 1A to the Act

    2. SCHEDULE 2

      AMENDMENTS TO THE MARKETING AUTHORIZATION REGULATIONS

      1. 1.(1) Schedule 2 to the Marketing Authorization Regulations (procedural provisions...

    3. SCHEDULE 3

      AMENDMENTS TO THE CLINICAL TRIALS REGULATIONS

      1. 1.In regulation 2 (interpretation), in paragraph (1), for the definition...

      2. 2.In regulation 19 (authorization procedure for clinical trials involving medicinal...

      3. 3.In regulation 26 (reference to appropriate committee or the Medicines...

      4. 4.(1) Regulation 31 (suspension or termination of clinical trial) shall...

      5. 5.For Schedule 5 (procedural provisions relating to the refusal or...

      6. 6.In Schedule 8 (procedural provisions relating to proposals to grant,...

    4. SCHEDULE 4

      CONSEQUENTIAL AMENDMENTS TO OTHER ENACTMENTS

      1. 1.In the Medicines (Extension to Antimicrobial Substances) Order 1973, in...

      2. 2.In the Medicines (Labelling) Regulations 1976, in regulation 17 (general...

      3. 3.In the Medicines (Administration of Radioactive Substances) Regulations 1978—

      4. 4.In the Medicines (Exemption from Licences) (Importation) Order 1984, in...

      5. 5.In the Medicines (Fixing of Fees Relating to Medicinal Products...

      6. 6.In the Medicines Act 1968 (Application to Radiopharmaceutical-associated Products) Regulations...

      7. 7.(1) The Unlicensed Medicinal Products for Human Use (Transmissible Spongiform...

    5. SCHEDULE 5

      TRANSITIONAL PROVISIONS

      1. PART 1 TRANSITIONAL PROVISIONS IN RELATION TO THE GRANT, RENEWAL, REVOCATION, SUSPENSION OR VARIATION OF LICENCES UNDER THE MEDICINES ACT 1968

        1. 1.Licence applications or proposals where appropriate committee has given provisional opinion before 30th October 2005

        2. 2.(1) This sub-paragraph applies if, before 30th October 2005, the...

        3. 3.(1) This paragraph and paragraph (4) apply if the applicant...

        4. 4.(1) When the applicant or holder has submitted the representations...

        5. 5.(1) This paragraph applies if— (a) the appropriate committee do...

        6. 6.(1) The appropriate committee shall— (a) take into account such...

        7. 7.Licence applications or proposals where appropriate committee has given advice to the licensing authority before 30th October 2005

        8. 8.(1) This paragraph applies where the licensing authority has not,...

        9. 9.(1) This paragraph applies where, before 30th October 2005, the...

        10. 10.(1) This paragraph applies where— (a) the applicant or holder...

        11. 11.(1) The Commission shall— (a) take into account—

        12. 12.Right to be heard by person appointed in relation to licence applications or proposals made before 30th October 2005

        13. 13.(1) This paragraph applies where, before 30th October 2005—

        14. 14.(1) This paragraph applies where, before 30th October 2005—

        15. 15.(1) This paragraph applies where— (a) before 30th October 2005,...

        16. 16.(1) This paragraph applies where— (a) paragraph 8 or 9...

        17. 17.Other licensing authority proposals notified to applicant or holder before 30th October 2005

        18. 18.Licence applications or proposals where there was no requirement to refer to appropriate committee before 30th October 2005

        19. 19.Applicant has given notice of wish to appear before person appointed prior to 30th October

        20. 20.Notice of wish to appear before person appointed given under this Part

        21. 21.Written representations made before 30th October 2005 or under this Part

        22. 22.Emergency suspensions in force on 30th October 2005

      2. PART 2 TRANSITIONAL PROVISIONS APPLICABLE TO OTHER PROVISIONS UNDER THE ACT

        1. 1.(1) This paragraph applies where, before 30th October 2005—

        2. 2.(1) This paragraph applies where, before 30th October 2005—

        3. 3.(1) This paragraph applies where, before 30th October 2005—

      3. PART 3 TRANSITIONAL PROVISIONS IN RELATION TO THE GRANT, RENEWAL, REVOCATION, SUSPENSION OR VARIATION OF MARKETING AUTHORIZATIONS UNDER THE MARKETING AUTHORIZATION REGULATIONS

        1. 1.Applications for, or proposals in relation to, marketing authorizations, where appropriate committee has given provisional opinion before 30th October 2005

        2. 2.(1) This sub-paragraph applies where, before 30th October 2005—

        3. 3.(1) This paragraph applies if the applicant or holder—

        4. 4.(1) When the applicant or holder has submitted the representations...

        5. 5.(1) This paragraph applies if— (a) the appropriate committee do...

        6. 6.(1) The appropriate committee shall— (a) take into account such...

        7. 7.Marketing authorisation applications or proposals where appropriate committee has given advice to the licensing authority before 30th October 2005

        8. 8.(1) This paragraph applies where the licensing authority have not,...

        9. 9.(1) This paragraph applies where, before 30th October 2005, the...

        10. 10.(1) This paragraph applies where— (a) the applicant or holder...

        11. 11.(1) The Commission shall— (a) take into account—

        12. 12.Right to be heard by person appointed in relation to marketing authorisation applications or proposals made before 30th October 2005

        13. 13.(1) This paragraph applies where, before 30th October 2005—

        14. 14.(1) This paragraph applies where— (a) before 30th October 2005,...

        15. 15.(1) This paragraph applies where— (a) paragraph 8 or 9...

        16. 16.Other licensing authority proposals notified to applicant or holder before 30th October 2005

        17. 17.Marketing authorization applications or proposals where there was no requirement to refer to appropriate committee before 30th October 2005

        18. 18.Applicant has given notice of wish to appear before person appointed prior to 30th October

        19. 19.Notice of wish to appear before person appointed given under this Part

        20. 20.Written representations made prior to 30th October or under this Part

        21. 21.Procedure in cases of emergency

      4. PART 4 TRANSITIONAL PROVISIONS APPLICABLE TO THE CLINICAL TRIALS REGULATIONS

        1. 1.Procedural provisions relating to the refusal or amendment of, or imposition of conditions relating to, clinical trial authorizations and the suspension or termination of clinical trials

        2. 2.(1) This paragraph applies where, before 30th October 2005—

        3. 3.(1) This paragraph applies where, before 30th October 2005—

        4. 4.Procedural provisions relating to proposals to grant, refuse to grant, vary, suspend or revoke manufacturing authorizations

        5. 5.If— (a) the applicant or holder made written representations to...

        6. 6.Where before 30th October— (a) an applicant or holder gives...

  9. Explanatory Note

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources